Brief: Alliqua Biomedical says co and Celgene entered into side letter agreement

Adynxx

15/03/2017 19:10

March 15 (Reuters) - Alliqua Biomedical Inc  ALQA.O  
    * On March 13, 2017, co and Celgene entered into a side 
letter agreement - sec filing 
    * co, chairman Jerome Zeldis entered into side letter 
agreement; Zeldis to conditionally waive MFN adjustment in 
securities purchase deal 
    * Celgene agreed to waive MFN adjustment in spa to extent 
MFN adjustment would cause Celgene to own in excess of 19.9% of 
co's common stock 
 
Further company coverage:  ALQA.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))